Indivior Pharmaceuticals (INDV) Other Working Capital Changes (2024 - 2026)

Indivior Pharmaceuticals' Other Working Capital Changes history runs 3 years deep, the most recent figure standing at $18.0 million for Q1 2026.

• On a quarterly basis, Other Working Capital Changes changed 0.0% year-over-year to $18.0 million in Q1 2026; TTM through Mar 2026 was -$49.0 million, a 232.43% decrease from a year earlier, with the FY2025 full-year figure at -$49.0 million, up 87.0% from the prior year.
• Other Working Capital Changes advanced to $18.0 million in Q1 2026 per INDV's latest filing, from -$11.0 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $18.0 million in Q1 2025 and bottomed at -$396.0 million in Q1 2024.
• The 3-year median for Other Working Capital Changes is $3.0 million (2024), against an average of -$45.3 million.
• Biggest YoY gain for Other Working Capital Changes was 104.55% in 2025; the steepest drop was 1733.33% in 2025.
• Year by year, Other Working Capital Changes stood at $12.0 million in 2024, then slumped by 191.67% to -$11.0 million in 2025, then jumped by 263.64% to $18.0 million in 2026.
• Per Business Quant, the three latest INDV Other Working Capital Changes figures stand at $18.0 million (Q1 2026), -$11.0 million (Q4 2025), and -$7.0 million (Q3 2025).